<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

Flat White

Europe detransitions

<em>Australia left behind as Europe distances itself from extreme gender affirmation</em>

17 September 2022

4:00 AM

17 September 2022

4:00 AM

An Australian obstetrician first warned the world of the dangers posed to unborn babies by the (then) widely prescribed maternal anti-nausea drug Thalidomide. Australia was relatively slow to halt its use – with devastating consequences still being felt decades on.

Today, despite warnings from clinicians in Australia and abroad, Australia risks repeating the same mistake over the medical treatment of children questioning their gender identity or suffering from gender dysphoria.

NSW Health Minister Brad Hazzard, John Hunter Hospital in Newcastle, and Maple Leaf House Transgender and Gender Diversity Clinic for children were all scrutinised by committee chair Greg Donnelly in the Budget Estimates Hearing...

Already a subscriber? Log in

Get 10 issues
for $10

Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $10.

  • Delivery of the weekly magazine
  • Unlimited access to spectator.com.au and app
  • Spectator podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock this article

REGISTER


Comments

Don't miss out

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Close